Browse Health


Education ?

Medical School
Duke University - Durham, NC in Master of Business Administration

Awards & Distinctions ?

Faculty Academic Excellence Award Wright State University School of Medicine
Outstanding OBGYN Clinical Faculty Member Wright State University School of Medicine
Fellow's Award - Outstanding Scientific Paper in Reproductive Endocrinology Armed Forces District Meeting ACOG
Selected Honored Member (1994/95) National Directory of Who's Who in Executives and Professionals
Physician's Recognition Award (1989-1994) American Medical Association
Resident's Award - Outstanding Scientific Paper Armed Forces District Meeting ACOG
American Medical Association Physician's Recognition Award (1989-1994)
Outstanding OB?GYN Clinical Faculty Member Wright State University School of Medicine
American Medical Association Physician's Recognition Award (1994-1997)
Alpha Omega Alpha (Honor Medical Society)
Alpha Omega Alpha (Honor Medical Society) Alpha Omega Alpha (Honor Medical Society)
Outstanding OB/GYN Resident in Teaching Keesler USAF Medical Center
The Best Doctors in America (1996/97) Southeast Region
Physician's Recognition Award (1994-1997) American Medical Association
Citation's Who's Who Registry of Rising Young Americans Citation Directories, Ltd., Princeton, NJ
Patients' Choice Award (2012 - 2015)
Compassionate Doctor Recognition (2012 - 2015)
On-Time Doctor Award (2015)
Uniformed Services University Of The Health Sciences F. Edward Herbert School Of Medicine - Bethesda Md
Clinical Assistant Professor
University Of South Carolina School Of Medicine - Columbia Sc
Assistant Professor
Medical University Of South Carolina College Of Medicine - Charleston Sc
Assistant Professor
Wright State University School Medicine - Dayton Oh
Chairman, Research Committee
Hormone Foundation
American Society for Reproductive Medicine
American Board of Obstetrics and Gynecology

Affiliations ?

Dr. Blauer is affiliated with 9 hospitals.

Hospital Affiliations



  • Alta View Hospital
    9660 S 1300 E, Sandy, UT 84094
    Top 25%
  • Utah Valley Regional Medical Center
    1034 N 500 W, Provo, UT 84604
    Top 25%
  • St Mark'S Hospital
    1200 E 3900 S, Salt Lake City, UT 84124
    Top 25%
  • American Fork Hospital
    170 N 1100 E, American Fork, UT 84003
    Top 50%
  • Orem Community Hospital
    Obstetrician & Gynecologist
    331 N 400 W, Orem, UT 84057
    Top 50%
  • Intermountain Medical Ctr
    5121 S Cottonwood St, Salt Lake City, UT 84107
  • Shady Grove Adventist Hospital, Rockville, Md
  • Inova Fairfax Hospital, Falls Church, Va
  • Greenville Memorial Medical Center
  • Publications & Research

    Dr. Blauer has contributed to 10 publications.
    Title Aggressive Outpatient Treatment of Ovarian Hyperstimulation Syndrome with Ascites Using Transvaginal Culdocentesis and Intravenous Albumin Minimizes Hospitalization.
    Date July 2003
    Journal Journal of Assisted Reproduction and Genetics

    PURPOSE: To assess the effectiveness of outpatient treatment of Ovarian Hyperstimulation Syndrome associated with ascites. METHODS: Forty-eight patients diagnosed with ovarian hyperstimulation and ascites from 2,246 consecutive in vitro fertilization cycles were retrospectively studied. Patients were treated with outpatient transvaginal culdocentesis and rehydration with intravenous crystalloids and albumin every 1-3 days until resolution of symptoms or hospitalization was required. Outcomes measured included incidences of hospitalization, pregnancy outcomes, cycle characteristics, and oocyte donors versus nondonors comparisons. RESULTS: No complications occurred from outpatient treatments, and 91.6% of patients avoided hospitalization. The pregnancy rate in patients undergoing transfer was 84.7%, and the spontaneous loss rate was 16%. Overall, the estradiol on day of hCG was 4331 pg/mL (range 2,211-8,167), ascites removed was 1910 cm3 (122-4,000), and number of outpatient treatments was 3.4 (1-14). Nondonors averaged more outpatient treatments than donors (3.97 vs. 1.85), but similar rates of hospitalization (3/35 vs. 1/13). CONCLUSIONS: Outpatient treatment consisting of culdocentesis, intravenous rehydration, and albumin minimized the need for hospitalization in hyperstimulated patients.

    Title Ectopic Luteinizing Hormone Secretion and Anovulation.
    Date January 2003
    Journal The New England Journal of Medicine
    Title Donor Oocyte Cytoplasmic Transfer Did Not Enhance Implantation of Embryos of Women with Poor Ovarian Reserve.
    Date December 2002
    Journal Journal of Assisted Reproduction and Genetics

    PURPOSE: To determine whether donor oocyte cytoplasm transferred into the oocytes of women < or = 40 years or with diminished ovarian reserve would enhance embryo quality, implantation, or pregnancy rates. METHODS: Study subjects included women > or = 40 years (15) or with abnormal FSH levels (3). Healthy volunteers (18) produced oocytes for cryopreservation. Donor oocytes were thawed and cytoplasm from surviving oocytes was injected with a single sperm into the cytoplasm of recipient oocytes. Outcome measures included embryo quality scores, implantation, and pregnancy rates. RESULTS: Eighteen donors produced 213 oocytes for cryopreservation and 39/171 (22.8%) survived thawing. Eighteen recipients initiated 25 IVF cycles with embryo transfer in 20 cycles after cytoplasmic transfer (CT). Four cycles resulted in three biochemical losses and one aneuploid clinical loss. Embryo quality did not improve with CT compared to pre-CT IVF cycles in six recipients. CONCLUSIONS: CT with cryopreserved donor oocyte cytoplasm did not enhance success in women with advanced reproductive age or low ovarian reserve.

    Title The Number of Embryos Available for Transfer Predicts Successful Pregnancy Outcome in Women over 39 Years with Normal Ovarian Hormonal Reserve Testing.
    Date April 2002
    Journal Journal of Assisted Reproduction and Genetics

    PURPOSE: The purpose was to determine whether the number of embryos available for transfer following IVF in women over age 39 predicted a successful pregnancy outcome. METHODS: Retrospective analysis of 455 consecutive IVF cycles in women > or = 40 years of age. RESULTS: Few cycles were canceled (29/455, 6.4%) or produced no embryos (5/455, 1.1%). Women 40-43 years of age with normal ovarian reserve had a significantly greater delivery rate when > or = 4 embryos were available for transfer than when < 4 embryos were available (17.8% versus 2.4%, P = 0.002). Subsequent IVF cycles, from women with normal FSH whose first cycle produced < 4 embryos, produced delivery rates of 13.0% when > or = 4 embryos were available. Women with abnormal ovarian reserve or age > or = 44 years had very low delivery rates (1.2% and 1.4% respectively). CONCLUSIONS: The number of embryos available for transfer significantly predicts delivery from IVF-ET among reproductively older women. Many women age 40-43 with normal ovarian reserve can achieve pregnancy through IVF.

    Title Pregnancy Rates in Sequential in Vitro Fertilization Cycles by Oocyte Donors(1).
    Date March 2001
    Journal Obstetrics and Gynecology

    OBJECTIVE: To evaluate the clinical outcome of in vitro fertilization (IVF) treatment cycles from individual oocyte donors who underwent multiple sequential donations. METHODS: We reviewed clinical outcome data from sequential anonymous oocyte donation cycles using donors who underwent multiple IVF stimulations. Donors were grouped by the interval between cycles and the cycle number (rank). The primary outcome measure was delivery rate by individual donor per retrieval from the combined derivative fresh and frozen embryo transfers. RESULTS: Duration and amount of gonadotropin therapy and the fertilization rates did not correlate significantly with the interval between cycles or cycle rank. Cumulative delivered pregnancy rates for cycles 1-6 were 51.5%, 54.6%, 50.5%, 51.5%, 51.1%, and 57.6%, respectively. Delivered pregnancy rates did not vary by interval between cycles. CONCLUSION: Young healthy presumed or proven fertile women can reliably donate oocytes for at least six cycles with the expectation of consistently high pregnancy rates.

    Title Validity and Cost-effectiveness of Antisperm Antibody Testing Before in Vitro Fertilization.
    Date May 1998
    Journal Fertility and Sterility

    OBJECTIVE: To determine the usefulness of and cost-effectiveness of antisperm antibody testing in the prediction of poor fertilization rates in couples undergoing IVF. DESIGN: Retrospective cohort study. SETTING: A hospital-based reproductive endocrinology and infertility practice. PATIENT(S): Male partners of 251 couples undergoing IVF between 1992 and 1997. MAIN OUTCOME MEASURE(S): Fertilization rates in couples undergoing conventional IVF. RESULT(S): One hundred nineteen couples were evaluated for antisperm antibodies; fertilization rates were similar in those couples whose husbands were and were not tested (64% versus 68%). Antisperm antibodies were detected in 16 men. Four (25%) of the 16 couples whose husbands had antisperm antibodies fertilized < or = 50% of oocytes, compared with 31 (30%) of the 103 couples whose husbands did not have these antibodies. Overall, 21 couples (8.4%) experienced complete fertilization failure. In a program that included antisperm antibody testing for selected couples and intracytoplasmic sperm injection (ICSI) for those who tested positive, it would cost $11,735 to prevent a fertilization failure (assuming ICSI were 100% effective), whereas it would cost $9,250 to perform ICSI in a second IVF cycle for those who initially failed. CONCLUSION(S): In this practice setting, antisperm antibody testing has low sensitivity in predicting low or no fertilization and does not appear to be cost-effective when selectively ordered as part of an IVF workup.

    Title Single-dose Pharmacokinetics of Sublingual Versus Oral Administration of Micronized 17 Beta-estradiol.
    Date March 1997
    Journal Obstetrics and Gynecology

    OBJECTIVE: To investigate the pharmacokinetic profiles of different doses of micronized 17 beta-estradiol administered by oral or sublingual routes. METHODS: Single doses of micronized 17 beta-estradiol were administered orally (1 mg, 0.5 mg) or sublingually (1 mg, 0.5 mg, 0.25 mg) to six postmenopausal women in a randomized clinical trial. We calculated pharmacokinetic parameters for estradiol (E2) and estrone (E1) of maximum serum concentration, time to maximum serum concentration, terminal half-life, area under the concentration curve, and oral clearance. Serum levels of E1 sulfate also were compared at 4, 12, and 24 hours after dosing. RESULTS: Sublingual administration resulted in rapid absorption with significantly higher E2 levels than did comparable oral dosing. Estrone levels did not vary with route of administration but correlated with the dosage administered. Estrone sulfate levels correlated with the dosage administered and also tended to be higher with sublingual administration. Sublingual administration resulted in a significantly lower E1 to E2 ratio during the 24 hours than did oral administration. CONCLUSION: Sublingual administration of micronized 17 beta-estradiol results in a rapid, burst-like absorption into the systemic circulation, yielding high E2 levels that fall rapidly over the first 6 hours.

    Title Use of a Gonadotropin-releasing Hormone Agonist in the Evaluation of Postmenopausal Virilization Due to Ovarian Hyperthecosis. A Case Report.
    Date October 1996
    Journal The Journal of Reproductive Medicine

    BACKGROUND: Hyperthecosis in a postmenopausal woman is a very rare cause of virilization, and only five cases have been reported previously. CASE: A woman presented with a nine-year history of increasing hirsutism and a mild virilization beginning in the perimenopausal period. Initial androgen metabolite concentrations suggested attenuated late-onset adrenal hyperplasia, but a trial of dexamethasone treatment was ineffective. Subsequent use of leuprolide acetate resulted in a biochemical and clinical improvement in the signs and symptoms. CONCLUSION: This case is unique because gonadotropin-releasing hormone agonist administration was utilized as both a diagnostic and therapeutic modality.

    Title Dehydroepiandrosterone Antagonizes the Suppressive Effects of Dexamethasone on Lymphocyte Proliferation.
    Date December 1991
    Journal Endocrinology

    Administration of dehydroepiandrosterone (DHEA) appears to have physiological effects opposing those of glucocorticoids in several animal models. Recently, immunomodulatory effects of treatment with DHEA have been described. This paper reports the effects of DHEA treatment on splenocyte blastogenic responses as well as thymic and spleen weights in C3H/HeN mice. Pretreatment of mice with sc DHEA (60 mg/ for 3 days in vivo antagonized the profound suppression of in vitro blastogenic responses seen in T- and B-lymphocytes after a single injection of dexamethasone (DEX; 60 mg/kg). Pretreatment with DHEA also significantly reduced dexamethasone-induced thymic and splenic atrophy. Splenic lymphocytes from DHEA-treated mice were markedly more resistant to in in vitro suppression of blastogenesis by DEX at 10(-6)-10(-8) M compared to lymphocytes from control mice. However, DHEA added to lymphocyte cultures in vitro over a concentration range from 10(-7)-10(-8) M failed to protect against suppression of mitogenic responses caused by addition of DEX to cultures. In summary, DHEA given in vivo antagonizes the suppressive actions of DEX on lymphoid target tissues in mice.

    Title The Effect of Intraperitoneal Progesterone on Postoperative Adhesion Formation in Rabbits.
    Date February 1988
    Journal Fertility and Sterility

    The immunosuppressive and anti-inflammatory properties of progesterone (P) have been established. The authors investigated whether the intraperitoneal instillation of P would lessen postoperative adhesion formation in New Zealand white rabbits undergoing pelvic surgical procedures. In phase I, severe, peritoneal lesions were made in the right uterine horn (n = 48). Animals were randomized to receive equal volumes of either (1) Ringer's lactate (RL); (2) 32% dextran 70 (HY; Hyskon Division, Pharmacia, Piscataway, NJ); (3) 500 mg P in oil (PO); or (4) 500 mg aqueous P (PA) at initial laparotomy. In phase II, the distal right uterine horn, including the mesosalpinx, was excised and microsurgical anastomosis was accomplished (n = 45). Aqueous P was not used in phase II; otherwise, the same agents were tested. Six weeks later, the severity of the adhesions formed was graded. The mean adhesion scores for the RL and HY groups were low for the right side in both phases and did not differ (P greater than 0.05). In contrast, higher scores were observed in all the P groups, regardless of the P preparation used or the surgical procedure performed (P less than 0.05).

    Similar doctors nearby

    Dr. Harry Hatasaka

    Obstetrics & Gynecology
    29 years experience
    Sandy, UT

    Dr. Elden Hansen

    Internal Medicine
    40 years experience
    Sandy, UT

    Dr. Eldon Hansen

    Obstetrics & Gynecology
    40 years experience
    Sandy, UT

    Dr. Gregory Tanner

    Obstetrics & Gynecology
    39 years experience
    Sandy, UT

    Dr. Alicia Jones

    Obstetrics & Gynecology
    6 years experience
    Sandy, UT

    Dr. Leon Hansen

    Obstetrics & Gynecology
    30 years experience
    Sandy, UT
    Search All Similar Doctors